Immunovant, Inc. (IMVT)

Immunovant Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	521.87	713.97	635.37	376.53	493.82	400.15
Cash & Short-Term Investments	521.87	713.97	635.37	376.53	493.82	400.15
Cash Growth	10.35%	12.37%	68.74%	-23.75%	23.41%	297.87%
Accounts Receivable	-	2.08	5.34	0.7	12.23	0.6
Other Receivables	1.97	0.43	0.17	0.19	0.63	0.55
Receivables	1.97	2.51	5.5	0.89	12.86	1.14
Prepaid Expenses	49.71	51.18	24.9	26.92	6.25	7.72
Total Current Assets	573.55	767.66	665.77	404.33	512.93	409.01
Property, Plant & Equipment	0.63	0.94	0.6	1.51	2.63	3.48
Other Long-Term Assets	8.78	7.62	-	-	-	-
Total Assets	582.96	776.22	666.37	405.84	515.56	412.49
Accounts Payable	6.92	17.66	7.16	1.35	18.63	2.43
Accrued Expenses	55.67	50.75	41.3	40.42	24.58	15.16
Current Portion of Leases	-	0.1	0.14	1.17	1.15	1.18
Other Current Liabilities	0.67	0.27	0.02	0.35	0.17	-
Total Current Liabilities	63.25	68.78	48.61	43.3	44.52	18.77
Long-Term Leases	-	-	-	0.05	1.22	2.24
Total Liabilities	63.25	68.78	48.61	43.34	45.74	21.01
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	2,005	1,945	1,442	927.98	824.8	590.43
Retained Earnings	-1,487	-1,240	-825.68	-566.35	-355.39	-198.66
Comprehensive Income & Other	1.45	1.46	1.91	0.85	0.4	-0.3
Shareholders' Equity	519.71	707.45	617.76	362.49	469.83	391.48
Total Liabilities & Equity	582.96	776.22	666.37	405.84	515.56	412.49
Total Debt	-	0.1	0.14	1.22	2.36	3.42
Net Cash (Debt)	521.87	713.87	635.23	375.31	491.45	396.73
Net Cash Growth	10.36%	12.38%	69.25%	-23.63%	23.88%	307.40%
Net Cash Per Share	3.17	4.71	4.60	3.05	4.48	4.52
Filing Date Shares Outstanding	175.28	170.92	146.05	130.41	116.51	97.98
Total Common Shares Outstanding	174.53	170.11	145.58	130.33	116.48	97.97
Working Capital	510.29	698.89	617.16	361.04	468.41	390.24
Book Value Per Share	2.98	4.16	4.24	2.78	4.03	4.00
Tangible Book Value	519.71	707.45	617.76	362.49	469.83	391.48
Tangible Book Value Per Share	2.98	4.16	4.24	2.78	4.03	4.00

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q